Research News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online 
  • New research strengthens the potential of mycoprotein as an alternative to meat
    7 February 2026

    New research strengthens the potential of mycoprotein as an alternative to meat

    Researcher Ricky Wang delved into these issues and recently presented his findings in his doctoral thesis In vitro Gastrointestinal Fate of Edible Filamentous Fungi : Protein and Mineral Digestibility for Food Applications.
  • 5 February 2026
    Blocking pain at the source : Hormone therapy rewires nerve signals in aging spines

    Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort that interferes with work, sleep, and daily activities. Yet in most cases, doctors cannot identify a clear structural cause, making long-term treatment difficult.

  • 4 February 2026
    Breakthrough in HIV Vaccine Research : Single-Shot Candidate Shows Neutralizing Success in Primates
    Scientists at The Wistar Institute have reported a major step forward in HIV vaccine development with a novel vaccine candidate that can induce neutralizing antibodies after a single immunization in nonhuman primates, an achievement never before demonstrated in the field.
  • 31 January 2026
    Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking
    Scientists have developed an advanced MXene-based wearable hydrogel sensor capable of continuous heart rate and respiratory monitoring under extreme conditions such as high heat, humidity and vigorous exercise.
  • 26 January 2026
    Scientists Decode How Cancer Cells Evade the Immune System, Opening Doors for Future Therapies

    An international team of researchers has uncovered a crucial mechanism that allows certain cancer cells to hide from the body’s immune defenses, a discovery that could reshape future cancer treatments. The study, led by scientists at Julius-Maximilians-Universität Würzburg (JMU) in collaboration with partners in the United States, reveals how the powerful cancer-driving protein MYC not only fuels tumor growth but also helps tumors remain undetected by the immune system.

  • 26 January 2026
    Heavy Lifetime Alcohol Use Linked to Higher Colorectal Cancer Risk, New Research Shows

    A new epidemiological study reported today finds that consistent heavy alcohol consumption over a lifetime is associated with a significantly increased risk of colorectal cancer, particularly rectal cancer, while reducing or quitting drinking may lower that risk. The findings were published online in the peer-reviewed journal Cancer.

  • 17 January 2026
    New Gut Protein Intelectin-2 Shows Promise as Natural Antimicrobial Defender
    Scientists have discovered an important protein in the human gut that can help protect the body from many harmful bacteria. This protein, called intelectin-2, acts as both a defensive barrier-builder and a bacteria-fighting molecule offering new insights into how the body defends itself at mucosal surfaces and pointing to possible future treatments against infections and antibiotic-resistant microbes.
  • 7 January 2026
    Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis
    Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.
  • 7 January 2026
    Infant gut molecules offer clues to type 1 Diabetes risk
    In a groundbreaking study, scientists have uncovered a new class of gut-derived molecules in infancy that could reshape how researchers understand the development of type 1 diabetes. The international research team, led by experts at the University of Turku and Örebro University, investigated stool samples from more than 300 children between the ages of 3 and 36 months, all of whom had a genetic predisposition for type 1 diabetes.
  • 3 January 2026
    Breakthrough study finds traditional Medicinal Fungus shows strong antidiabetic potential

    A new peer-reviewed study has revealed that Sanghuangporus quercicola, a medicinal fungus long used in traditional practices across Asia, produces significantly varied secondary metabolites under different cultivation conditions, with notable in vitro antidiabetic activity emerging from the analyses.

Subscribe to Research News